What "revenue cycle management automation" actually covers

Revenue cycle management automation means using software, rules-based bots, or AI agents to handle the tasks between a patient scheduling a visit and the practice actually getting paid for it. That spans three zones: front-end (eligibility verification, prior authorization, patient estimates), middle (charge capture, coding, claim scrubbing), and back-end (claim submission, denial management, payment posting, A/R follow-up). Every vendor page on page one of Google splits it this way, and the split is useful. What none of them tell you is that the split assumes one clean system feeding data through all three zones. For a single-location practice on one PM system, that's a fair assumption. For a PE-backed group that has acquired six practices in three years and inherited five different EHRs, it isn't.

That gap is the actual decision most CFOs and VPs of Revenue Cycle are facing right now, and it's the question nobody selling an RCM platform wants to answer honestly: do you buy a platform built for the clean case, or do you build automation that fits the messy one you actually have?

Why the buy-a-platform pitch breaks down after a PE roll-up

A bought RCM platform assumes standardized inputs. Roll-ups don't have those. Once you've merged four practices onto four different practice management systems with four different fee schedules and four sets of payer contracts, the "automate front-to-back" pitch from vendors like Waystar or TruBridge runs into a wall: their AI and RPA claims are built and tested against a single source of truth, not a stitched-together one.

Here's what actually happens on the ground. Coding rules that were locally correct at Practice A conflict with the global rule set the new platform expects. Eligibility checks come back clean for one entity's payer mix and wrong for another's, because the platform's connector was built for the acquirer's contracts, not the acquired practice's. Denial rates climb, not because the staff got worse at their jobs, but because the automation is applying one logic tree to five different realities. MGMA's practice benchmarking work has tracked denial rates rising in exactly this kind of post-merger period, and it's rarely a coding-skill problem; it's a data-standardization problem masquerading as one.

This is the piece the vendor SERP skips entirely. Automation Anywhere, SS&C Blue Prism, and the RCM-specific platforms all pitch RPA and AI against a single, homogenous data source. Blue Prism's own use-case list is a solid inventory of what's automatable in principle: eligibility checks, claim status queries, payment posting, prior-auth status tracking. Every item on that list assumes the underlying systems already agree on what a "clean claim" looks like. Multi-entity groups don't have that agreement yet. That's the diagnosis step everyone skips, and it's exactly where projects stall six months after the platform goes live.

What RCM platforms are actually good at buying

Be fair to the vendors here: for a single-system, single-payer-mix practice, buying is usually the right call. If you're a 20-provider group on one EHR with a stable payer mix and no acquisition plans, a platform like Waystar, athenahealth, or R1's RCM offering will do the front/middle/back-end automation Blue Prism and Automation Anywhere describe, reliably, without you needing to build anything. You get vendor support, a known implementation timeline, and a track record across thousands of similar practices. There's no case for building custom software to replicate what a mature platform already does well.

The buy case gets weaker exactly at the point where your organization stops looking like the reference customer the platform was built for: multiple PM/EHR systems, inconsistent payer contracts across entities, or a business model (like an RCM outsourcer serving client practices on their own disparate systems) where "standardize everything onto our platform" isn't an option because you don't own the underlying systems.

Where custom AI agents outperform a bought platform

Custom automation wins in the gaps platforms won't touch: reconciling logic across systems the vendor never built a connector for. Three places this shows up consistently.

Eligibility verification across mixed PM systems. CAQH's annual Index has tracked the cost gap between manual and electronic eligibility and claim-status transactions for years, and the gap is large enough that automating it is almost always worth doing. The problem for multi-entity groups isn't whether to automate eligibility checks, it's that a bought platform typically wants one integration pattern across all locations. An agent built for your specific stack can call five different payer portals and five different PM APIs and normalize the output into one format your billing team actually uses, without forcing every practice onto the same system first.

Denial triage that needs entity-specific logic. A bought platform applies one rule set to route denials. If Practice A's contract with a payer differs from Practice B's, a generic denial-routing rule either over-flags or misses real recoverable denials. Custom logic that knows which entity, which contract, and which payer it's dealing with catches more, and routes it to the right person faster. This is close cousin work to what we've covered on the appeals and denials layer of this same build-vs-buy question, which goes deeper into that specific slice.

A/R follow-up that has to bridge systems. Following up on unpaid claims across five PM systems means logging into five places, or building an integration a platform vendor has no incentive to prioritize because it only serves you, not their broader customer base. That's a natural build.

Front-end prior authorization deserves its own mention here too, since it has a regulatory clock attached. The CMS interoperability rule taking effect in 2027 changes how prior-auth decisions have to move electronically, and the prior-auth piece of the revenue cycle has its own compliance clock worth planning against separately from the rest of this decision.

How do you improve revenue cycle management without replacing your EHR

You improve it by automating the connective tissue between systems, not by forcing every practice onto one system first. That's the direct answer, and it's the question most CFOs actually have when they start this evaluation, because "just switch everyone to the same EHR" is a multi-year, multi-million-dollar project most PE-backed groups can't absorb mid-hold-period.

In practice this looks like a small number of targeted agents sitting on top of your existing stack: one that normalizes eligibility responses across your PM systems into a single dashboard, one that triages denials using entity-aware rules, one that flags claims likely to deny before submission based on patterns specific to each practice's payer mix. None of that requires ripping out an EHR. It requires someone who understands both the clinical/billing workflow and the integration layer well enough to build connectors that a platform vendor would never build, because they only serve one customer.

The HFMA, which is the trade association for healthcare CFOs and revenue cycle leaders rather than a vendor with something to sell, makes a version of this same point in its March 2025 piece on where AI and automation are actually landing in revenue cycle operations: the wins are concentrated in specific, well-scoped tasks, not in a single platform swap. Workday's own perspective on RCM automation ROI makes a similar case from the enterprise-finance side, though naturally it's framed around adopting their platform rather than building narrow automation on top of what you have.

The compliance layer buyers skip

Every RCM workflow touches protected health information, which means every build-vs-buy decision here is also a data-ownership decision, whether anyone frames it that way or not. Buying a platform means PHI flows through that vendor's infrastructure under a Business Associate Agreement. That's fine, and standard, and most vendors handle it competently. But it also means you've handed a third party operational visibility into your billing data across every merged entity, and you're now dependent on their retention policies, their breach history, and their contract terms if you ever need to leave.

Building means the automation runs on infrastructure you control, or that a firm builds and hands to you outright. For groups in regulated, PHI-heavy operations, that distinction matters more than it gets credit for during vendor evaluation. We've written more specifically about what HIPAA-compliant AI actually requires beyond a signed BAA, and it's worth reading before signing anything, because a BAA covers you legally without necessarily telling you where your data actually sits, who can query it, or what happens to it if you switch vendors two years from now.

This is also where Genta AI Solutions runs a different playbook than most implementation partners: for regulated, data-sensitive clients we deploy self-hosted, open-source models on the client's own infrastructure with zero data retention outside their environment. No PHI leaving your control to sit inside someone else's model logs.

A decision framework: buy, build, or augment

Most groups don't need a binary choice. The honest framework looks like this. It's the healthcare version of the general buy vs build AI framework we use across every system.

Buy when you're on one PM/EHR system, your payer mix is stable, and you have no near-term acquisition plans. The platform's connectors were built for exactly your situation, and paying for that fit beats building your own.

Augment when you're mostly standardized but have one or two systems that don't play well with your primary platform, usually from a recent acquisition that hasn't been migrated yet. Keep the platform for the bulk of the work, and build a narrow agent or integration to handle the systems it can't reach.

Build when you're an RCM outsourcer serving clients on their own disparate systems, or a multi-entity group with three or more PM/EHR systems and no realistic near-term consolidation plan. At that point, a bought platform's core assumption (one standardized data source) doesn't hold, and you're paying for automation that will need constant manual workarounds anyway.

One honest note from our own client work: when we automated utility billing for a multi-entity energy services firm, the diagnosis found that most of the fix wasn't AI at all, it was process automation and system integration work that had nothing to do with model intelligence. The same is often true here. A lot of what looks like an "AI problem" in a multi-system RCM environment is actually an integration and data-normalization problem first, and the AI layer (denial triage logic, prediction of likely-to-deny claims) only earns its place once that foundation exists.

If you're working through this decision and trying to figure out which of your systems can be bridged versus which need custom agents built around them, that diagnosis is exactly what Genta AI Solutions' Discovery phase maps out before any code gets written, and it's a conversation we're happy to compare notes on. For groups that land on "build," our workflow automation work is built specifically for layering onto existing PM/EHR systems rather than replacing them.

Frequently asked questions

What is revenue cycle management automation?

It's the use of software, rules-based bots, or AI agents to handle tasks across the patient-to-payment cycle: eligibility verification, prior authorization, charge capture, coding, claim submission, denial management, and payment posting. The goal is fewer manual touches and faster, more accurate reimbursement, though how well it works depends heavily on how standardized your underlying systems already are.

What are the 7 steps of the revenue cycle?

Most frameworks describe: patient registration and scheduling, eligibility verification, charge capture, medical coding, claim submission, payment posting, and denial/A-R follow-up. Automation vendors map their tools onto these steps, but the steps themselves assume a single, clean data source moving between them, which multi-system practices rarely have.

Is AI replacing RPA in revenue cycle management?

Not replacing it, complementing it. RPA handles rules-based, repetitive tasks like data entry between systems. AI agents handle judgment-heavy work like denial triage, prediction of likely-to-deny claims, or reconciling conflicting coding rules across merged entities. Most production RCM automation today combines both rather than choosing one.

What are the top RCM companies or platforms?

Waystar, TruBridge, athenahealth, R1 RCM, and Workday's finance suite are among the more established names, each with different strengths in claims scrubbing, denial workflows, or enterprise finance integration. None of them are built to reconcile five different PM systems out of the box; that's a separate build decision, not a feature you're buying alongside the platform.

How do you improve revenue cycle management without replacing your EHR?

By automating the connective tissue between existing systems instead of consolidating onto one platform first. Targeted agents for eligibility normalization, entity-aware denial routing, and cross-system A/R follow-up can materially cut manual work and denial rates without a multi-year EHR migration project.